v3.21.2
Investment in Cenovus Energy
9 Months Ended
Sep. 30, 2021
Investment In Cenovus Energy [Abstract]  
Investment in Cenovus Energy
Note 5—Investment in Cenovus
 
Energy
Our investment in Cenovus Energy
 
(CVE) shares is carried on our consolidated
 
balance sheet at fair value of $
1.4
billion based on the closing price of $
10.06
 
per share on the NYSE on the last trading
 
day of the quarter.
 
At
September 30, 2021 and December 31, 2020, we held
141
 
million and
208
 
million shares of CVE common stock,
respectively.
 
At September 30, 2021, our investment
 
approximated
7
 
percent of the issued and outstanding
 
CVE
common stock.
During the third quarter,
 
we sold
47
 
million shares of our CVE common stock, recognizing
 
proceeds of $
404
 
million.
 
Since we began disposing of our CVE shares
 
in May 2021, we have sold
67
 
million shares for total proceeds
 
of $
584
million, of which $
569
 
million was received by the end of the third
 
quarter.
 
Subject to market conditions, we
intend to continue to decrease
 
our investment over time.
 
All gains and losses are recognized
 
within “Other income (loss)” on our consolidated
 
income statement.
 
Proceeds
related to the sale of our CVE shares are
 
presented within “Cash Flows from Investing
 
Activities” on our
consolidated statement
 
of cash flows.
for information related
 
to fair value measurement
.
Millions of Dollars
Three Months Ended
Nine Months Ended
September 30
September 30
2021
2020
2021
2020
Total
 
Net gain (loss) on equity securities
$
17
(162)
743
(1,302)
Less: Net gain (loss) on equity securities sold during
 
the period
(50)
-
177
-
Unrealized gain (loss) on equity securities
 
still held at
 
the reporting date
$
67
(162)
566
(1,302)